Â鶹Éç

Medicine supply

A marketing authorisation works to ensure that when a medicine reaches a patient it works in the same high quality way every time.

Medicines are highly regulated and theÌýMedicines and Healthcare Products Regulatory Agency (MHRA) issuesÌýa ‘marketingÌýauthorisation’ for every medicine.

The marketing authorisation governsÌýnot only what the medicine is for and how it should be used, but also the details of the formulation, storage requirements and shelf life, so that the medicine that reaches patientsÌýworks andÌýisÌýofÌýthe sameÌýhigh qualityÌýevery time.

To learn more about the work of the MHRA, visit the Ìýsection of the MHRA website.Ìý

The MHRA also issuesÌý‘manufacturing authorisations’Ìýwhich entitle a company to manufacture medicines in the UK. ÌýCompaniesÌýneed toÌýdemonstrate that they comply with good manufacturing practice and pass regular inspections of the manufacturing site. To find out more about this, visit theÌýÌýÌý

The Â鶹Éçworks through its Pharmaceutical Quality Expert Network to monitor regulatory activity on these topics and participate in the development of legislation at both national and European levels. The Network also facilitates the exchange between members of good practice in these important areas.Ìý

Environmental health and safetyÌý

Good environmental health and safety performance is a major consideration in all aspects of pharmaceutical industry activity.Ìý

Through the Environmental HealthÌýand Safety Network, we monitor regulatory activity on these topics and participate actively in the development of legislation at both national and European levels, as well as facilitating the sharing of good practice amongst member companies. 

Related content in this section:

Ìý

Last modified: 12 November 2024

Last reviewed: 12 November 2024